MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).
| Outcome | beta | se | p | method | nSNP | cis/trans | coloc |
|---|---|---|---|---|---|---|---|
| Bulimia nervosa | -0.082 | 0.0273 | 0.0027 | Inverse variance weighted | 2 | trans | NA |
| Bulimia nervosa | -0.082 | 0.0273 | 0.0027 | Inverse variance weighted | 2 | cis | NA |
| Diagnoses - main ICD10: R07 Pain in throat and chest | 0.0849 | 0.0317 | 0.00736 | Inverse variance weighted | 2 | trans | NA |
| Diagnoses - main ICD10: R07 Pain in throat and chest | 0.0849 | 0.0317 | 0.00736 | Inverse variance weighted | 2 | cis | NA |
| Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation | 0.109 | 0.0424 | 0.00988 | Inverse variance weighted | 2 | trans | NA |
| Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation | 0.109 | 0.0424 | 0.00988 | Inverse variance weighted | 2 | cis | NA |
| Diagnoses - main ICD10: M23 Internal derangement of knee | 0.104 | 0.0411 | 0.0118 | Inverse variance weighted | 2 | trans | NA |
| Diagnoses - main ICD10: M23 Internal derangement of knee | 0.104 | 0.0411 | 0.0118 | Inverse variance weighted | 2 | cis | NA |
| Non-cancer illness code self-reported: hypothyroidism or myxoedema | -0.0729 | 0.0324 | 0.0245 | Inverse variance weighted | 2 | trans | NA |
| Non-cancer illness code self-reported: hypothyroidism or myxoedema | -0.0729 | 0.0324 | 0.0245 | Inverse variance weighted | 2 | cis | NA |
| Primary sclerosing cholangitis | 0.194 | 0.0866 | 0.0253 | Inverse variance weighted | 2 | trans | NA |
| Primary sclerosing cholangitis | 0.194 | 0.0866 | 0.0253 | Inverse variance weighted | 2 | cis | NA |
| …and 203 more outcomes (see JSON) |
No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).
65 association rows across 37 traits (53 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.
| Trait | best p | lead SNP | n assoc | study | MR status |
|---|---|---|---|---|---|
| Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransf | 2e-257 | rs4683355 | 2 | GCST90249061 | no MR -> candidate analysis |
| GASK1A protein levels | 5e-106 | rs73074963 | 15 | GCST90469306 | no MR -> candidate analysis |
| Serum levels of protein POMGNT2 | 3e-50 | rs2936818 | 1 | GCST90089363 | no MR -> candidate analysis |
| Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransf | 8e-34 | rs79762832 | 1 | GCST90238222 | no MR -> candidate analysis |
| Blood protein levels | 4e-30 | rs729654 | 1 | GCST006585 | no MR -> candidate analysis |
| Height | 8e-29 | rs1320160 | 1 | GCST90245848 | no MR -> candidate analysis |
| Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransf | 9e-27 | rs729654 | 1 | GCST90242495 | no MR -> candidate analysis |
| CCL17 protein levels | 2e-25 | rs11719635 | 1 | GCST90468569 | no MR -> candidate analysis |
| Hematological traits (multi-trait analysis) | 1e-23 | rs60671097 | 2 | GCST90838669 | no MR -> candidate analysis |
| Insomnia | 5e-17 | rs9875582 | 8 | GCST90131901 | no MR -> candidate analysis |
| CCL7 protein levels | 1e-14 | rs11719635 | 1 | GCST90468585 | no MR -> candidate analysis |
| Externalizing behaviour (multivariate analysis) | 3e-13 | rs76887862 | 1 | GCST90061435 | no MR -> candidate analysis |
| …and 25 more traits (see JSON) |
Top diseases by Open Targets association (of 61 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.
| Disease | genetic assoc. | burden (ExWAS) | causal status | MR status |
|---|---|---|---|---|
| muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 | 0.896 | — | established (curated) | no MR -> candidate analysis |
| muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 | 0.796 | — | established (curated) | no MR -> candidate analysis |
| muscular dystrophy-dystroglycanopathy, type A | 0.608 | — | established (curated) | no MR -> candidate analysis |
| hereditary disease | 0.561 | — | established (curated) | no MR -> candidate analysis |
| ankylosing spondylitis | 0.427 | — | common-variant locus | no MR -> candidate analysis |
| Severe hydrocephalus | 0.426 | — | established (curated) | no MR -> candidate analysis |
| placenta praevia | 0.324 | — | common-variant locus | no MR -> candidate analysis |
| ovarian neoplasm | 0.309 | — | common-variant locus | no MR -> candidate analysis |
| response to antihypertensive drug | 0.167 | — | common-variant locus | no MR -> candidate analysis |
| spondylolisthesis | 0.106 | — | common-variant locus | no MR -> candidate analysis |
| ovarian dysfunction | 0.088 | — | common-variant locus | no MR -> candidate analysis |
| insomnia | 0.051 | — | common-variant locus | no MR -> candidate analysis |
| cleft palate | 0.043 | — | common-variant locus | no MR -> candidate analysis |
| Hypercholesterolemia | 0.041 | — | common-variant locus | MR: beta=0.0266, p=0.0635 (trans) |
| attention deficit-hyperactivity disorder | 0.033 | — | common-variant locus | no MR -> candidate analysis |
Of the 15 rows above, 14 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.
| Layer | Result |
|---|---|
| ChEMBL druggability | not available — no ChEMBL target (undrugged) |
| gnomAD constraint | pLI=5.5e-10, LOEUF=1.14 — LoF-tolerant |
| GWAS Catalog | 101 unique SNPs / 179 rows |
| ClinVar | 508 records; 4 pathogenic in sample of 30 |
| PharmGKB/ClinPGx | no annotations |
phenome — Top 30 of 61 associated diseases by overall score. genetic_association aggregates GWAS common-variant AND rare-variant evidence. These are ASSOCIATIONS (loci), not causal claims.chembl — No ChEMBL target for ‘POMGNT2’.clinvar — Pathogenic count is over the 30 record(s) retrieved, NOT over all 508 ClinVar records for this gene; it is a sample, not a rate.gwas_traits — Top 20 of 37 traits by best p-value, aggregated from 65 association rows. These are GWAS ASSOCIATIONS (loci), not causal claims; mapped genes at a locus are not necessarily the effector gene.uniprot: https://www.uniprot.org/uniprotkb/Q8NAT1 — UniProt release 2026_02 (10-June-2026)mr_outcomes: https://epigraphdb.org/pqtl/ — EpiGraphDB pQTL MR (Zheng et al., Nat Genet 2020) — pre-computed two-sample MR; retrieved, not computed by this agent; EpiGraphDB build 1.0, pQTL dataset v3.0phenome: https://platform.opentargets.org/target/ENSG00000144647/associations — Open Targets data release 26.06gnomad: https://gnomad.broadinstitute.org/gene/POMGNT2 — gnomAD constraint via GraphQL API (reference genome GRCh38)gwas: https://www.ebi.ac.uk/gwas/genes/POMGNT2 — GWAS Catalog REST (live; release not exposed by this endpoint)clinvar: https://www.ncbi.nlm.nih.gov/clinvar/?term=POMGNT2%5Bgene%5D — ClinVar build Build260809-1055.1gwas_traits: https://www.ebi.ac.uk/gwas/genes/POMGNT2 — GWAS Catalog search API (live; release not exposed)